Anupam Rasayan India rose 3.96% to Rs 767.20 after the company received and signed Letter of Intent (LoI) worth Rs 135 crore with a Japanese multinational chemical company for supplying a life sciences related speciality chemical product.
The company will enter into a long-term contract with the Japanese multinational firm for next four years to supply this life science related speciality chemical product.
Speaking about the order, Anand Desai, managing director of Anupam Rasayan, said, This order will further strengthen our revenue and profitability visibility and also showcases the quality of the product allowing the customer to depend upon the company on long term basis making Anupam Rasayan, a preferred partner for these MNCs.
Anupam Rasayan India is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India.
The company's consolidated net profit surged to Rs 32.12 crore in Q1 FY22 from Rs 0.23 crore in Q1 FY21. Net sales rose 72.61% YoY to Rs 233.68 crore during the quarter.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
